Updated on November 12, 2026
Where Things Stand
The Fifth Circuit has not yet issued a decision in Texas Chemistry Council v. EPA, No. 24-60193. The court heard oral arguments on June 1, 2026, and the consolidated challenge remains pending. ADAO and its public-health partners continue to defend the scientific foundation of EPA’s March 2024 chrysotile rule while challenging provisions that leave preventable exposure risks insufficiently addressed.
The developments below bring the timeline up to date, preserving the key history behind Part 1 and adding the latest litigation activity.
Timeline: From TSCA Reform to the Fifth Circuit
Building the Part 1 Foundation (2016–2020)
June 2016 – TSCA reform creates a new framework: Congress passes the Frank R. Lautenberg Chemical Safety for the 21st Century Act, strengthening EPA’s authority to evaluate and manage risks from high-priority chemicals, including asbestos, under TSCA Section 6.
December 22, 2020 – Federal court orders better asbestos data: In ADAO’s Chemical Data Reporting (CDR) case, Judge Edward Chen rules that EPA’s denial of ADAO’s petition was “arbitrary and capricious” and orders the agency to revise its reporting requirements to capture asbestos data. The decision highlights major gaps in EPA’s understanding of asbestos use and exposure.
Late December 2020 – EPA completes the Part 1 risk evaluation: EPA’s final risk evaluation for chrysotile asbestos finds unreasonable risks to workers, occupational non-users, consumers, and bystanders for all identified ongoing uses. EPA finds no unreasonable risk to the environment. ADAO criticizes the evaluation as too narrow and incomplete.
ADAO Challenges the Risk Evaluation (2020–2021)
December 2020–January 2021 – ADAO seeks judicial review: ADAO, joined by public-health organizations and asbestos scientists, petitions the Ninth Circuit to review EPA’s Part 1 risk evaluation, arguing that it is piecemeal, excludes legacy asbestos, and understates the disease burden.
Early 2021 – ADAO presses EPA to address legacy asbestos: ADAO issues a TSCA Section 20 60-day notice of intent to sue, seeking a proper evaluation of legacy asbestos and pointing to the Ninth Circuit’s decision in Safer Chemicals and the documented gaps in EPA’s asbestos data.
2021 – EPA commitments help establish the path to Part 2: Settlement-related commitments in ADAO v. EPA and allied cases press EPA to address data gaps and develop a broader Part 2 evaluation covering legacy asbestos and additional fiber types.
From Proposed Rule to Final Part 1 Rule (2022–March 2024)
April 2022 – EPA proposes the Part 1 chrysotile rule: EPA proposes restrictions on specified ongoing uses of chrysotile asbestos under TSCA Section 6(a). ADAO submits comments urging faster phase-outs, coverage of additional chrysotile products, and stronger workplace protections.
March 27–28, 2024 – EPA finalizes the Part 1 rule: EPA issues its first TSCA Section 6 asbestos risk-management rule, prohibiting manufacture (including import), processing, distribution in commerce, and commercial use for specified conditions of use, with staggered compliance deadlines. The rule is limited to chrysotile and does not resolve the risks posed by legacy asbestos or all other asbestos fiber types.
Litigation and Reconsideration (April 2024–2025)
April 19, 2024 – ADAO petitions for review: ADAO and co-petitioners challenge the final rule, arguing that it is incomplete and under-protective. Their concerns include lengthy chlor-alkali phase-out periods, inadequate safeguards for asbestos already in place, environmental release pathways, and omitted ongoing chrysotile uses.
2024–2025 – Challenges are consolidated in the Fifth Circuit: Public-health, labor, environmental, and industry challenges are consolidated in Texas Chemistry Council v. EPA, No. 24-60193. ADAO’s briefing argues that EPA excluded documented ongoing uses, allowed compliance periods inconsistent with TSCA’s requirement to act as soon as practicable, and failed to prevent foreseeable resumption of discontinued uses.
Mid-2025 – EPA signals reconsideration: EPA agrees to reconsider aspects of the Part 1 rule, and the Fifth Circuit allows time for that process. This affects elements of the rule’s implementation and compliance schedule while EPA reviews its determinations.
September 17, 2025 – ADAO details its objections: In its reply brief, ADAO points to evidence of additional ongoing chrysotile imports that EPA did not include, challenges the length of chlor-alkali compliance deadlines, and asks the court to remand the rule with instructions to broaden its scope and shorten the timelines.
Fifth Circuit Proceedings and Latest Developments (2026)
Early 2026 – Briefing concludes: Briefing is completed in the consolidated Fifth Circuit case, and the court schedules oral argument for mid-2026.
May 6, 2026 – Olin withdraws from the industry challenge: Olin Corporation files a stipulation of dismissal and exits the consolidated challenge to EPA’s rule, narrowing the industry group seeking to overturn or weaken the chrysotile phase-out.
May 20, 2026 – ACC and allied petitioners drop their challenge to EPA’s science: The American Chemistry Council (ACC) and allied industry petitioners notify the Fifth Circuit that they will no longer pursue arguments challenging EPA’s underlying chrysotile risk evaluation and scientific findings. The remaining industry challenge focuses on the rule’s scope, timing, and implementation.
May 27, 2026 – Fifth Circuit raises standing questions: The court directs the parties to be prepared to address whether petitioners have established Article III standing, including the implications of the court’s en banc decision in United States v. Texas for organizational-standing arguments.
June 1, 2026 – Fifth Circuit hears oral arguments: In New Orleans, the court hears arguments on both the public-health challenge to protections ADAO considers insufficient and industry challenges to EPA’s rule, particularly its requirements for the chlor-alkali sector. The panel questions the parties about TSCA, compliance deadlines, and implementation.
June 2, 2026 – Court requests supplemental standing briefing: Following argument, the Fifth Circuit asks the parties for additional briefing on standing.
June 10, 2026 – ADAO and 17 co-petitioners submit supplemental materials: ADAO and its co-petitioners file an eight-page letter brief and four additional declarations, building on three earlier declarations. The materials describe ongoing risks to workers, firefighters, health and safety professionals, and community members, and ask the court to decide ADAO’s claims on the merits.
June 22, 2026 – EPA asks the court to strike the supplemental declarations: EPA argues that the court authorized additional briefing but not new evidence and asks that the declarations be excluded. Alternatively, EPA requests an opportunity to respond if the court considers them. The filing continues the dispute over whether the public-health petitioners have adequately established standing.
November 12, 2026 – Fifth Circuit decision remains pending: The latest ADAO update reports that the case is still awaiting the Fifth Circuit’s decision. No outcome is stated. ADAO continues to defend the scientific basis for the rule and advocate for stronger safeguards.
Why This Case Matters
Part 1 was the first asbestos risk-management rule finalized under the reformed TSCA, but it addresses specified ongoing uses of chrysotile—not the full range of asbestos fibers and legacy materials already present in homes, schools, workplaces, and communities.
ADAO’s litigation seeks to preserve the rule’s scientific foundation while addressing gaps in its coverage and the pace of its protections. Industry petitioners’ decision to stop challenging EPA’s underlying risk evaluation narrows one part of the dispute; it does not resolve the remaining challenges or ADAO’s claims.
Part 1 is also connected to EPA’s broader Part 2 work on legacy asbestos and ADAO’s support for the Alan Reinstein Ban Asbestos Now (ARBAN) Act. ADAO maintains that a comprehensive federal ban is needed to close gaps that a chrysotile-only rule cannot address.
Congressional Context
As the 119th Congress enters its final weeks, the midterm-election results have been described as a “blue tsunami,” signaling a changed political landscape heading into the 120th Congress. That transition is relevant to the broader legislative effort to advance ARBAN and secure a comprehensive asbestos ban. It does not alter the status of the Part 1 appeal, which remains before the Fifth Circuit. ADAO’s message remains that protecting public health should transcend politics and that bipartisan cooperation is essential to lasting asbestos protections.